Gene Panel Market Segmentation
Gene Panel Technique Outlook (USD Billion, 2018-2032)
Amplicon Based Approach
Hybridization Based Approach
Gene Panel Design Outlook (USD Billion, 2018-2032)
Predesigned Gene Panel
Customized Gene Panel
Gene Panel Loss Products Regional Outlook (USD Billion, 2018-2032)
North America Outlook (USD Billion, 2018-2032)
North America Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
North America Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
US Outlook (USD Billion, 2018-2032)
US Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
US Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
CANADA Outlook (USD Billion, 2018-2032)
CANADA Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
CANADA Gene Panel by Design
Predesigned Gene Pane
Customized Gene Panel
Europe Outlook (USD Billion, 2018-2032)
Europe Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Europe Gene Panel by Design
Predesigned Gene Pane
Customized Gene Panel
Germany Outlook (USD Billion, 2018-2032)
Germany Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Germany Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
France Outlook (USD Billion, 2018-2032)
France Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
France Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
UK Outlook (USD Billion, 2018-2032)
UK Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
UK Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
ITALY Outlook (USD Billion, 2018-2032)
ITALY Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
ITALY Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
SPAIN Outlook (USD Billion, 2018-2032)
Spain Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Spain Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
REST OF EUROPE Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Asia-Pacific Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
China Outlook (USD Billion, 2018-2032)
China Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
China Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Japan Outlook (USD Billion, 2018-2032)
Japan Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Japan Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
India Outlook (USD Billion, 2018-2032)
India Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
India Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Australia Outlook (USD Billion, 2018-2032)
Australia Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Australia Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Rest of Asia-Pacific Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Rest of the World Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Middle East Outlook (USD Billion, 2018-2032)
Middle East Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Middle East Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Africa Outlook (USD Billion, 2018-2032)
Africa Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Africa Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
Latin America Outlook (USD Billion, 2018-2032)
Latin America Gene Panel by Technique
Amplicon Based Approach
Hybridization Based Approach
Latin America Gene Panel by Design
Predesigned Gene Panel
Customized Gene Panel
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 18
1.1.1 MARKET SYPNOSIS 18
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS 20
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 22
3.2 DATA MINING 22
3.3 SECONDARY RESEARCH 23
3.4 PRIMARY RESEARCH 24
3.5 FORECASTING METHODS 25
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26
3.6.1 BOTTOM-UP APPROACH 27
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 INCREASING PREVALENCE OF CANCER 30
4.2.2 BENEFITS OF GENE PANELS 30
4.3 RESTRAINTS 32
4.3.1 LIMITATIONS IN GENE PANEL TESTING AND INACCURACY OF TEST 32
4.4 OPPORTUNITIES 32
4.4.1 GROWTH POTENTIAL IN EMERGING COUNTRIES 32
4.5 CHALLENGES 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 34
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 R&D 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION 37
5.2.4 MARKETING & SALES 37
5.3 INVESTMENT SCENARIO 37
5.3.1 INVESTMENT RISKS 38
5.3.2 MARKET OUTLOOK 38
5.3.3 COMPETITORS 38
5.3.4 PROJECTIONS 38
5.4 PRICING ANALYSIS 38
6 GENE PANEL MARKET, BY PRODUCT & SERVICE
6.1 OVERVIEW 39
6.2 TEST KITS 40
6.3 TESTING SERVICES 40
7 GENE PANEL MARKET, BY TECHNIQUE
7.1 OVERVIEW 42
7.2 AMPLICON-BASED APPROACH 43
7.3 HYBRIDIZATION-BASED APPROACH 44
8 GENE PANEL MARKET, BY DESIGN
8.1 OVERVIEW 45
8.2 PREDESIGNED GENE PANELS 46
8.3 CUSTOMIZED GENE PANELS 46
9 GENE PANEL MARKET, BY APPLICATION
9.1 OVERVIEW 48
9.2 CANCER RISK ASSESSMENT 50
9.3 DIAGNOSIS 51
9.4 PHARMACOGENETICS 51
10 GENE PANEL MARKET, BY END USER
10.1 OVERVIEW 52
10.2 HOSPITALS 53
10.3 DIAGNOSTIC LABORATORIES 54
11 GLOBAL GENE PANEL MARKET, BY REGION
11.1 OVERVIEW 55
11.2 AMERICAS 57
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.2.1 NORTH AMERICA 60
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.2.1.1 US 63
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.2.1.2 CANADA 66
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.2.2 LATIN AMERICA 68
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3 EUROPE 72
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1 WESTERN EUROPE 75
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.1 GERMANY 78
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.2 UK 81
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.3 FRANCE 83
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.4 ITALY 86
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.5 SPAIN 88
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.1.6 REST OF WESTERN EUROPE 91
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.3.2 EASTERN EUROPE 93
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4 ASIA-PACIFIC 97
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.1 JAPAN 100
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.2 CHINA 103
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.3 INDIA 105
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.4 AUSTRALIA 108
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.5 SOUTH KOREA 111
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.4.6 REST OF ASIA-PACIFIC 113
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.5 MIDDLE EAST & AFRICA 117
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.5.1 UNITED ARAB EMIRATES 120
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.5.2 SAUDI ARABIA 123
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
11.5.3 REST OF MIDDLE EAST & AFRICA 125
GENE PANEL MARKET, BY PRODUCT & SERVICE
GENE PANEL MARKET, BY TECHNIQUE
GENE PANEL MARKET, BY DESIGN
GENE PANEL MARKET, BY APPLICATION
GENE PANEL MARKET, BY END USER
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW 129
12.2 COMPANY RANKING ANALYSIS 129
12.3 KEY DEVELOPMENT ANALYSIS 130
13 COMPANY PROFILES
13.1 AGILENT TECHNOLOGIES, INC. 131
13.1.1 COMPANY OVERVIEW 131
13.1.2 FINANCIAL OVERVIEW 132
13.1.3 PRODUCTS/SERVICES OFFERED 132
13.1.4 KEY DEVELOPMENTS 133
13.1.5 SWOT ANALYSIS 133
13.1.6 KEY STRATEGIES 133
13.2 THERMO FISHER SCIENTIFIC 134
13.2.1 COMPANY OVERVIEW 134
13.2.2 FINANCIAL OVERVIEW 134
13.2.3 PRODUCTS/SERVICES OFFERED 135
13.2.4 KEY DEVELOPMENTS 135
13.2.5 SWOT ANALYSIS 136
13.2.6 KEY STRATEGIES 136
13.3 F. HOFFMANN-LA ROCHE LTD 137
13.3.1 COMPANY OVERVIEW 137
13.3.2 FINANCIAL OVERVIEW 137
13.3.3 PRODUCTS/SERVICES OFFERED 138
13.3.4 KEY DEVELOPMENTS 138
13.3.5 SWOT ANALYSIS 138
13.3.6 KEY STRATEGIES 139
13.4 QIAGEN 140
13.4.1 COMPANY OVERVIEW 140
13.4.2 FINANCIAL OVERVIEW 140
13.4.3 PRODUCTS/SERVICES OFFERED 141
13.4.4 KEY DEVELOPMENTS 141
13.4.5 SWOT ANALYSIS 142
13.4.6 KEY STRATEGIES 142
13.5 ILLUMINA INC. 143
13.5.1 COMPANY OVERVIEW 143
13.5.2 FINANCIAL OVERVIEW 143
13.5.3 PRODUCTS/SERVICES OFFERED 144
13.5.4 KEY DEVELOPMENTS 144
13.5.5 SWOT ANALYSIS 145
13.5.6 KEY STRATEGIES 145
13.6 BGI 146
13.6.1 COMPANY OVERVIEW 146
13.6.2 FINANCIAL OVERVIEW 146
13.6.3 PRODUCTS/SERVICES OFFERED 147
13.6.4 KEY DEVELOPMENTS 147
13.6.5 SWOT ANALYSIS 147
13.6.6 KEY STRATEGIES 148
13.7 INTEGRATED DNA TECHNOLOGIES, INC. 149
13.7.1 COMPANY OVERVIEW 149
13.7.2 FINANCIAL OVERVIEW 150
13.7.3 PRODUCTS/SERVICES OFFERED 150
13.7.4 KEY DEVELOPMENTS 151
13.7.5 SWOT ANALYSIS 151
13.7.6 KEY STRATEGIES 151
13.8 GENEWIZ 152
13.8.1 COMPANY OVERVIEW 152
13.8.2 FINANCIAL OVERVIEW 153
13.8.3 PRODUCTS/SERVICES OFFERED 153
13.8.4 KEY DEVELOPMENTS 154
13.8.5 SWOT ANALYSIS 154
13.8.6 KEY STRATEGIES 154
13.9 NOVOGENE CORPORATION 155
13.9.1 COMPANY OVERVIEW 155
13.9.2 FINANCIAL OVERVIEW 155
13.9.3 PRODUCTS/SERVICES OFFERED 155
13.9.4 KEY DEVELOPMENTS 155
13.9.5 SWOT ANALYSIS 156
13.9.6 KEY STRATEGIES 156
13.10 PERSONALIS, INC. 157
13.10.1 COMPANY OVERVIEW 157
13.10.2 FINANCIAL OVERVIEW 158
13.10.3 YEARLY COMPARISION 158
13.10.3.1 REVENUE COMPARISON OF THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 158
13.10.3.2 RESEARCH AND DEVELOPMENT EXPENSES COMPARISON OF THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 158
13.10.3.3 SOURCES OF LIQUIDITY 159
13.10.4 MATERIAL AGREEMENTS 159
13.10.5 COMPETITION 159
13.10.6 PRODUCTS/SERVICES OFFERED 160
13.10.7 KEY DEVELOPMENTS 160
13.10.8 SWOT ANALYSIS 160
13.10.9 KEY STRATEGIES 160
13.11 GATC BIOTECH AG 161
13.11.1 COMPANY OVERVIEW 161
13.11.2 FINANCIAL OVERVIEW 161
13.11.3 BUSINESS COMBINATIONS OF EUROFINS SCIENTIFIC, 2020 163
13.11.4 PRODUCTS/SERVICES OFFERED 164
13.11.5 KEY DEVELOPMENTS 164
13.11.6 SWOT ANALYSIS 164
13.11.7 KEY STRATEGIES 164
13.12 ARCHERDX, INC 165
13.12.1 COMPANY OVERVIEW 165
13.12.2 FINANCIAL TRANSACTIONS 165
13.12.3 PRODUCTS/SERVICES OFFERED 166
13.12.4 KEY DEVELOPMENTS 166
13.12.5 SWOT ANALYSIS 167
13.12.6 KEY STRATEGIES 167
13.13 GENEDX 168
13.13.1 COMPANY OVERVIEW 168
13.13.2 FINANCIAL OVERVIEW 168
13.13.3 PRODUCTS/SERVICES OFFERED 168
13.13.4 KEY DEVELOPMENTS 169
13.13.5 SWOT ANALYSIS 169
13.13.6 KEY STRATEGIES 169
13.14 CENTOGENE AG 170
13.14.1 COMPANY OVERVIEW 170
13.14.2 FINANCIAL OVERVIEW 171
13.14.2.1 FINANCIAL OPERATIONS OVERVIEW 172
13.14.2.1.1 COST OF SALES 172
13.14.2.1.2 RESEARCH AND DEVELOPMENT EXPENSES 172
13.14.2.2 FINANCIAL OVERVIEW, BY SOLUTION 172
13.14.2.2.1 PHARMACEUTICAL 172
13.14.2.2.2 DIAGNOSTICS 172
13.14.3 PRODUCTS/SERVICES OFFERED 173
13.14.4 KEY DEVELOPMENTS 173
13.14.5 SWOT ANALYSIS 173
13.14.6 KEY STRATEGIES 173
14 APPENDIX
14.1 REFERENCES 174
14.2 RELATED REPORTS 174
15 LIST OF TABLES`
TABLE 1 LIST OF ASSUMPTIONS 20
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24
TABLE 3 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 40
TABLE 4 GLOBAL GENE PANEL MARKET FOR TEST KITS, BY REGION, 2020-2027 (USD MILLION) 40
TABLE 5 GLOBAL GENE PANEL MARKET FOR TESTING SERVICES, BY REGION, 2020-2027 (USD MILLION) 41
TABLE 6 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 43
TABLE 7 GLOBAL GENE PANEL MARKET FOR AMPLICON-BASED APPROACH, BY REGION, 2020-2027 (USD MILLION) 43
TABLE 8 GLOBAL GENE PANEL MARKET FOR HYBRIDIZATION-BASED APPROACH, BY REGION, 2020-2027 (USD MILLION) 44
TABLE 9 GLOBAL GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 46
TABLE 10 GLOBAL GENE PANEL MARKET FOR PREDESIGNED GENE PANELS, BY REGION, 2020-2027 (USD MILLION) 46
TABLE 11 GLOBAL GENE PANEL MARKET FOR CUSTOMIZED GENE PANELS, BY REGION, 2020-2027 (USD MILLION) 47
TABLE 12 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 49
TABLE 13 GLOBAL GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 49
TABLE 14 GLOBAL GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 49
TABLE 15 GLOBAL GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 50
TABLE 16 GLOBAL GENE PANEL MARKET FOR CANCER RISK ASSESSMENT, BY REGION, 2020-2027 (USD MILLION) 50
TABLE 17 GLOBAL GENE PANEL MARKET FOR DIAGNOSIS, BY REGION, 2020-2027 (USD MILLION) 51
TABLE 18 GLOBAL GENE PANEL MARKET FOR PHARMACOGENETICS, BY REGION, 2020-2027 (USD MILLION) 51
TABLE 19 GLOBAL GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 53
TABLE 20 GLOBAL GENE PANEL MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 53
TABLE 21 GLOBAL GENE PANEL MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020-2027 (USD MILLION) 54
TABLE 22 GLOBAL GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 56
TABLE 23 AMERICAS: GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 57
TABLE 24 AMERICAS: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 57
TABLE 25 AMERICAS: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 58
TABLE 26 AMERICAS: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 58
TABLE 27 AMERICAS: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 58
TABLE 28 AMERICAS: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 29 AMERICAS: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 30 AMERICAS: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 31 AMERICAS: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 60
TABLE 32 NORTH AMERICA: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 60
TABLE 33 NORTH AMERICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 61
TABLE 34 NORTH AMERICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 61
TABLE 35 NORTH AMERICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 61
TABLE 36 NORTH AMERICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 61
TABLE 37 NORTH AMERICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 38 NORTH AMERICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 39 NORTH AMERICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 40 NORTH AMERICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 63
TABLE 41 US: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 63
TABLE 42 US: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 63
TABLE 43 US: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 64
TABLE 44 US: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64
TABLE 45 US: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 64
TABLE 46 US: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 47 US: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 48 US: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 65
TABLE 49 CANADA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 66
TABLE 50 CANADA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 66
TABLE 51 CANADA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 66
TABLE 52 CANADA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 67
TABLE 53 CANADA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 67
TABLE 54 CANADA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 67
TABLE 55 CANADA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 56 CANADA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 68
TABLE 57 LATIN AMERICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 68
TABLE 58 LATIN AMERICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 69
TABLE 59 LATIN AMERICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 69
TABLE 60 LATIN AMERICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 69
TABLE 61 LATIN AMERICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 70
TABLE 62 LATIN AMERICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 70
TABLE 63 LATIN AMERICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 70
TABLE 64 LATIN AMERICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 71
TABLE 65 EUROPE: GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 72
TABLE 66 EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 72
TABLE 67 EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 73
TABLE 68 EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 73
TABLE 69 EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 73
TABLE 70 EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 73
TABLE 71 EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 74
TABLE 72 EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 74
TABLE 73 EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 74
TABLE 74 WESTERN EUROPE: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 75
TABLE 75 WESTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 75
TABLE 76 WESTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 76
TABLE 77 WESTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 76
TABLE 78 WESTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76
TABLE 79 WESTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 77
TABLE 80 WESTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 77
TABLE 81 WESTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 77
TABLE 82 WESTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 78
TABLE 83 GERMANY: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 78
TABLE 84 GERMANY: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 78
TABLE 85 GERMANY: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 79
TABLE 86 GERMANY: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 79
TABLE 87 GERMANY: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 79
TABLE 88 GERMANY: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 80
TABLE 89 GERMANY: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 80
TABLE 90 GERMANY: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 80
TABLE 91 UK: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 81
TABLE 92 UK: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 81
TABLE 93 UK: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 81
TABLE 94 UK: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 82
TABLE 95 UK: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 82
TABLE 96 UK: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 82
TABLE 97 UK: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 83
TABLE 98 UK: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 83
TABLE 99 FRANCE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 83
TABLE 100 FRANCE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 84
TABLE 101 FRANCE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 84
TABLE 102 FRANCE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84
TABLE 103 FRANCE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 84
TABLE 104 FRANCE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 105 FRANCE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 106 FRANCE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 85
TABLE 107 ITALY: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 86
TABLE 108 ITALY: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 86
TABLE 109 ITALY: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 86
TABLE 110 ITALY: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87
TABLE 111 ITALY: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 87
TABLE 112 ITALY: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 87
TABLE 113 ITALY: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 88
TABLE 114 ITALY: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 88
TABLE 115 SPAIN: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 88
TABLE 116 SPAIN: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 89
TABLE 117 SPAIN: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 89
TABLE 118 SPAIN: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 89
TABLE 119 SPAIN: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 89
TABLE 120 SPAIN: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 90
TABLE 121 SPAIN: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 90
TABLE 122 SPAIN: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 90
TABLE 123 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 91
TABLE 124 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 91
TABLE 125 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 91
TABLE 126 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92
TABLE 127 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 92
TABLE 128 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027
(USD MILLION) 92
TABLE 129 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027
(USD MILLION) 93
TABLE 130 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 93
TABLE 131 EASTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 93
TABLE 132 EASTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 94
TABLE 133 EASTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 94
TABLE 134 EASTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94
TABLE 135 EASTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 95
TABLE 136 EASTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 95
TABLE 137 EASTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 95
TABLE 138 EASTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 96
TABLE 139 ASIA-PACIFIC: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 97
TABLE 140 ASIA-PACIFIC: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 98
TABLE 141 ASIA-PACIFIC: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 98
TABLE 142 ASIA-PACIFIC: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 98
TABLE 143 ASIA-PACIFIC: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98
TABLE 144 ASIA-PACIFIC: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 99
TABLE 145 ASIA-PACIFIC: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 99
TABLE 146 ASIA-PACIFIC: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 99
TABLE 147 ASIA-PACIFIC: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 100
TABLE 148 JAPAN: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 100
TABLE 149 JAPAN: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 100
TABLE 150 JAPAN: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 101
TABLE 151 JAPAN: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 101
TABLE 152 JAPAN: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 101
TABLE 153 JAPAN: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 102
TABLE 154 JAPAN: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 102
TABLE 155 JAPAN: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 102
TABLE 156 CHINA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 103
TABLE 157 CHINA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 103
TABLE 158 CHINA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 103
TABLE 159 CHINA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 104
TABLE 160 CHINA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 104
TABLE 161 CHINA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 104
TABLE 162 CHINA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 105
TABLE 163 CHINA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 105
TABLE 164 INDIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 105
TABLE 165 INDIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 106
TABLE 166 INDIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 106
TABLE 167 INDIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 106
TABLE 168 INDIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 169 INDIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 170 INDIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 171 INDIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 108
TABLE 172 AUSTRALIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 108
TABLE 173 AUSTRALIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 108
TABLE 174 AUSTRALIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 109
TABLE 175 AUSTRALIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 109
TABLE 176 AUSTRALIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 109
TABLE 177 AUSTRALIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 110
TABLE 178 AUSTRALIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 110
TABLE 179 AUSTRALIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 110
TABLE 180 SOUTH KOREA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 111
TABLE 181 SOUTH KOREA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 111
TABLE 182 SOUTH KOREA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 111
TABLE 183 SOUTH KOREA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112
TABLE 184 SOUTH KOREA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 112
TABLE 185 SOUTH KOREA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 112
TABLE 186 SOUTH KOREA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 113
TABLE 187 SOUTH KOREA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 113
TABLE 188 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 113
TABLE 189 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 114
TABLE 190 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 114
TABLE 191 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 114
TABLE 192 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 115
TABLE 193 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027
(USD MILLION) 115
TABLE 194 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 115
TABLE 195 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 116
TABLE 196 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 117
TABLE 197 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 117
TABLE 198 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 118
TABLE 199 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 118
TABLE 200 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 118
TABLE 201 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 119
TABLE 202 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027
(USD MILLION) 119
TABLE 203 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 119
TABLE 204 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 120
TABLE 205 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 120
TABLE 206 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 120
TABLE 207 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 121
TABLE 208 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 121
TABLE 209 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 121
TABLE 210 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027
(USD MILLION) 122
TABLE 211 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 122
TABLE 212 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 122
TABLE 213 SAUDI ARABIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 123
TABLE 214 SAUDI ARABIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 123
TABLE 215 SAUDI ARABIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 123
TABLE 216 SAUDI ARABIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 124
TABLE 217 SAUDI ARABIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 124
TABLE 218 SAUDI ARABIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 124
TABLE 219 SAUDI ARABIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 125
TABLE 220 SAUDI ARABIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 125
TABLE 221 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 125
TABLE 222 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 126
TABLE 223 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 126
TABLE 224 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 126
TABLE 225 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 127
TABLE 226 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027
(USD MILLION) 127
TABLE 227 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027
(USD MILLION) 127
TABLE 228 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 128
TABLE 229 TOP MANUFACTURERS IN THE GLOBAL GENE PANEL MARKET 129
TABLE 230 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 132
TABLE 231 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 133
TABLE 232 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED 135
TABLE 233 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS 135
TABLE 234 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 138
TABLE 235 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 138
TABLE 236 QIAGEN: PRODUCTS/SERVICES OFFERED 141
TABLE 237 QIAGEN: KEY DEVELOPMENTS 141
TABLE 238 ILLUMINA INC.: PRODUCTS/SERVICES OFFERED 144
TABLE 239 ILLUMINA INC.: KEY DEVELOPMENTS 144
TABLE 240 BGI: PRODUCTS OFFERED 147
TABLE 241 BGI: KEY DEVELOPMENTS 147
TABLE 242 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCTS OFFERED 150
TABLE 243 INTEGRATED DNA TECHNOLOGIES, INC.: KEY DEVELOPMENTS 151
TABLE 244 GENEWIZ: PRODUCTS OFFERED 153
TABLE 245 GENEWIZ: KEY DEVELOPMENTS 154
TABLE 246 NOVOGENE CORPORATION: PRODUCTS OFFERED 155
TABLE 247 NOVOGENE CORPORATION: KEY DEVELOPMENTS 155
TABLE 248 PERSONALIS, INC.: PRODUCTS/SERVICES OFFERED 160
TABLE 249 GATC BIOTECH AG: PRODUCTS/SERVICES OFFERED 164
TABLE 250 ARCHERDX INC: PRODUCTS/SERVICES OFFERED 166
TABLE 251 ARCHERDX INC: KEY DEVELOPMENTS 166
TABLE 252 GENEDX: PRODUCTS/SERVICES OFFERED 168
TABLE 253 CENTOGENE AG: PRODUCTS/SERVICES OFFERED 173
16 LIST OF FIGURES
FIGURE 1 GLOBAL GENE PANEL MARKET: MARKET STRUCTURE 21
FIGURE 2 BREAKDOWN OF PRIMARY RESPONDENTS 25
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 27
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL GENE PANEL MARKET 29
FIGURE 5 DRIVER IMPACT ANALYSIS 31
FIGURE 6 RESTRAINT IMPACT ANALYSIS 32
FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL GENE PANEL MARKET 34
FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL GENE PANEL MARKET 36
FIGURE 9 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020 (%) 39
FIGURE 10 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2023-2032 (USD MILLION) 39
FIGURE 11 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2020 (%) 42
FIGURE 12 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2023-2032 (USD MILLION) 42
FIGURE 13 GLOBAL GENE PANEL MARKET, BY DESIGN, 2020 (%) 45
FIGURE 14 GLOBAL GENE PANEL MARKET, BY DESIGN, 2023-2032 (USD MILLION) 45
FIGURE 15 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2020 (%) 48
FIGURE 16 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 48
FIGURE 17 GLOBAL GENE PANEL MARKET, BY END USER, 2020 (%) 52
FIGURE 18 GLOBAL GENE PANEL MARKET, BY END USER, 2023-2032 (USD MILLION) 52
FIGURE 19 GLOBAL GENE PANEL MARKET, BY REGION, 2020(%) 55
FIGURE 20 GLOBAL GENE PANEL MARKET, BY REGION, 2023-2032 (USD MILLION) 55
FIGURE 21 AMERICAS: GENE PANEL MARKET, BY REGION, 2020 (%) 57
FIGURE 22 NORTH AMERICA: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 60
FIGURE 23 EUROPE: GENE PANEL MARKET, BY REGION, 2020 (%) 72
FIGURE 24 WESTERN EUROPE: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 75
FIGURE 25 ASIA-PACIFIC: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 97
FIGURE 26 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 117
FIGURE 27 GENE PANEL MARKET, COMPETITIVE LANDSCAPE (% SHARE) 130
FIGURE 28 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 132
FIGURE 29 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 133
FIGURE 30 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 134
FIGURE 31 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 136
FIGURE 32 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 137
FIGURE 33 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 138
FIGURE 34 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 140
FIGURE 35 QIAGEN: SWOT ANALYSIS 142
FIGURE 36 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT 143
FIGURE 37 ILLUMINA INC.: SWOT ANALYSIS 145
FIGURE 38 BGI: FINANCIAL OVERVIEW SNAPSHOT 146
FIGURE 39 BGI: SWOT ANALYSIS 147
FIGURE 40 INTEGRATED DNA TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 150
FIGURE 41 INTEGRATED DNA TECHNOLOGIES, INC.: SWOT ANALYSIS 151
FIGURE 42 FINANCIAL OVERVIEW GENEWIZ 153
FIGURE 43 GENEWIZ: SWOT ANALYSIS 154
FIGURE 44 NOVOGENE CORPORATION: SWOT ANALYSIS 156
FIGURE 45 FINANCIAL OVERVIEW PERSONALIS, INC. 158
FIGURE 46 PERSONALIS, INC.: SWOT ANALYSIS 160
FIGURE 47 FINANCIAL OVERVIEW GATC BIOTECH AG 161
FIGURE 48 GATC BIOTECH AG: SWOT ANALYSIS 164
FIGURE 49 ARCHERDX INC: SWOT ANALYSIS 167
FIGURE 50 GENEDX: SWOT ANALYSIS 169
FIGURE 51 CENTOGENE AG FINANCIAL OVERVIEW 171
FIGURE 52 CENTOGENE AG: SWOT ANALYSIS 173
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
